| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 101K | $627K | $6.20 | Feb 8, 2024 | Direct |
| RENOVARO INC. | Chief Financial Officer | Option to purchase shares of common stock | 250K | Jan 21, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RENB | RENOVARO INC. | Jan 21, 2025 | 1 | $0 | 4 | Feb 25, 2025 | Chief Financial Officer |
| RENB | RENOVARO INC. | Jan 6, 2025 | 0 | $0 | 3 | Jan 13, 2025 | Chief Financial Officer |
| TELO | Telomir Pharmaceuticals, Inc. | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | Chief Financial Officer |